We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Overretraction May Cause Gastrectomy Sleeve Stenosis

By HospiMedica International staff writers
Posted on 12 Dec 2011
Overretracting the greater curvature is likely to be the cause of the majority of symptomatic stenoses (SS) following laparoscopic sleeve gastrectomy (LSG), according to a new study.

Researchers at the University of Texas (UT) Health Sciences Center (San Antonio, USA; www.uthscsa.edu) conducted a retrospective study of 230 patients (83% female, mean age 49.5 years, and a mean body mass index (BMI) of 43) who underwent LSG between October 2008 and December 2010 to determine the incidence, etiology, and management options for SS after LSG. More...
The operative technique used a 36 French bougie with a buttressed staple line, as well as selective segmental suture imbrication of the staple line, based on the surgeon’s judgment. All patients underwent an intraoperative leak test by esophagogastroduodenoscopy.

The researchers found that the overall rate of major complications was 9.5%, with a 3.5% stenosis rate and a 3% bleeding rate. Of these, eight patients had short-segment stenosis; all of the patients were managed successfully using endoscopic balloon dilation. The patients with SS were found to be significantly younger than the other patients were. The researchers also found that most short-segment SS can be managed endoscopically, but for long-segment stenosis, complications are more likely to require conversion to bypass. The study was published in the November 2011 issue of Surgical Endoscopy.

“Overretraction may cause the stomach to be stretched over the bougie, which can be misleading in terms of how much space you are actually leaving behind when you take the bougie out and the pouch recoils,” said lead author Amit Parikh, DO, of the department of surgery.“Meticulous technique is of utmost importance, specifically focusing on avoiding over-retraction at the greater curve during division of the stomach as well as not overly abutting the bougie when the division is taking place.”

LSG is a restrictive form of weight loss surgery intended for the morbidly obese, which permanently reduces the size of the stomach by removing the lateral 2/3rds of the stomach with a stapling device. While the stomach is drastically reduced in size, its function is preserved, and there is no malabsorption of nutrients and supplements. LSG avoids the problems associated with bypass forms of weight loss surgery including anemia, intestinal obstruction or blockage, osteoporosis, and protein and vitamin deficiency, since about 100-200 mL of stomach capacity is maintained and there are very few restrictions on food consumption.

Related Links:

University of Texas (UT) Health Sciences Center




Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.